Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ £¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

72 ÒÚÔª£¡°¢Ë¹Àû¿µÍê³ÉÊÕ¹ºÒ»¼ÒÌåÄÚϸ°ûÖÎÁƹ«Ë¾ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-05-21
|
»á¼ûÁ¿£º

0522.jpgÒ½ÏßÒ©ÎÅ

1. 5ÔÂ21ÈÕ£¬ £¬£¬£¬£¬ÈñÕý»ùÒòÐû²¼£¬ £¬£¬£¬£¬ÆäÑз¢µÄÓÃÓÚÖÎÁÆ×ª¼××´ÏÙËØÂѰ×Ïà¹Øµí·ÛÑù±äÐÔ£¨ATTR£©µÄÒÔÖ¬ÖÊÄÉÃ׿ÅÁ££¨LNP£©ÎªÔØÌåµÄÌåÄÚ»ùÒò±à¼­Á¢ÒìÒ© ART001 ÒÑ»ñµÃÃÀ¹ú FDA ÊÚÓèµÄÔÙÉúҽѧÏȽøÁÆ·¨£¨RMAT£©×ʸñÈ϶¨¡£¡£¡£¡£¡£¡£

2. 5Ô 20ÈÕ£¬ £¬£¬£¬£¬CDE¹ÙÍø¹«Ê¾£¬ £¬£¬£¬£¬âýÐËÉúÃüÉ걨µÄÊæÈð»ù°ÂÂØÈü×¢ÉäÒºÄâÄÉÈëÓÅÏÈÉóÆÀ£¬ £¬£¬£¬£¬Ë³Ó¦Ö¢Îª CLDN18.2 ±í´ïÑôÐÔ¡¢ÖÁÉÙ¶þÏßÖÎÁÆÊ§°ÜµÄÍíÆÚθ/ʳ¹ÜθÁ¬Ïµ²¿ÏÙ°©¡£¡£¡£¡£¡£¡£

3. 5ÔÂ20ÈÕ£¬ £¬£¬£¬£¬ÉϺ£Ò½Ò©Ðû²¼Í¨¸æ³Æ£¬ £¬£¬£¬£¬¹«Ë¾ÆìÏÂÕã½­ÐÅÒêÈð¾ôÖÆÒ©ÓÐÏÞ¹«Ë¾¿ËÈÕ»ñµÃÃÀ¹úʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨FDA£©Åú×¼µÄ¿·ËáĪÃ×ËɱÇÅçÎí¼ÁµÄ¼òÂÔÐÂÒ©ÉêÇ루ANDA£©¡£¡£¡£¡£¡£¡£¸ÃÒ©Æ·Ö÷ÒªÓÃÓÚÔ¤·ÀºÍÖÎÁÆÇàÉÙÄê¼°³ÉÈ˵ļ¾½ÚÐÔ±ÇÑ×£¬ £¬£¬£¬£¬ÒÔ¼°ÖÎÁƳÉÈ˰éÓбÇÏ¢ÈâµÄÂýÐÔ±Çñ¼Ñס£¡£¡£¡£¡£¡£

4. 5ÔÂ20ÈÕ£¬ £¬£¬£¬£¬¾ÝCDE¹ÙÍøÐÂÎÅ£¬ £¬£¬£¬£¬±±¾©¶«·½Ô˼ÎÒ©ÒµÓÐÏÞ¹«Ë¾ÁªºÏÉêÇëÒ©Æ·¡°ËÕ»ÆÖ¹¿È¿ÅÁ£¡±£¬ £¬£¬£¬£¬»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí£¬ £¬£¬£¬£¬Ë³Ó¦Ö¢£ºÉË·çºó¿ÈËÔ¼°¿Ö°Ô±äÒìÐÔÏø´­¡£¡£¡£¡£¡£¡£

ͶÈÚÒ©ÊÂ

1. 5ÔÂ20ÈÕ£¬ £¬£¬£¬£¬°¢Ë¹Àû¿µÐû²¼ÀÖ³ÉÍê³É¶Ô EsoBiotec µÄÊÕ¹º£¬ £¬£¬£¬£¬ÉúÒâ×ܼÛÖµ´ï¸ß´ï 10 ÒÚÃÀÔª£¨Ô¼ 72.38 ÒÚÔª£©£¬ £¬£¬£¬£¬ÆäÖаüÀ¨ 4.25 ÒÚÃÀÔªµÄÔçÆÚ¸¶¿îºÍ¸ß´ï 5.75 ÒÚÃÀÔªµÄºóÐøÀï³Ì±®¸¶¿î¡£¡£¡£¡£¡£¡£¸ÃÉúÒâÖ§¸¶Ô¤¼Æ½«ÓÚ 2025 ÄêµÚ¶þ¼¾¶ÈÍê³É£¬ £¬£¬£¬£¬µ«ÐèÖª×ãÀÏÀý³É½»Ìõ¼þ²¢»ñµÃî¿Ïµ»ú¹¹Åú×¼¡£¡£¡£¡£¡£¡£

2. 5ÔÂ20ÈÕ£¬ £¬£¬£¬£¬¾¸ÒòÒ©ÒµÓëCRISPR TherapeuticsÐû²¼Ë«·½¸æ¿¢Õ½ÂÔÏàÖúͬ°é¹ØÏµ£¬ £¬£¬£¬£¬½«Ð¯ÊÖÍÆ½øsiRNAÁÆ·¨µÄÁªºÏ¿ª·¢ÓëÉÌÒµ»¯Àú³Ì¡£¡£¡£¡£¡£¡£ÐÂΟåÌåÏÖ£¬ £¬£¬£¬£¬¸ÃÏàÖú½«Ë«·½ÔÚÑз¢Ó빤ҵ»¯·½ÃæµÄ»¥²¹ÄÜÁ¦ÏàÁ¬Ïµ£¬ £¬£¬£¬£¬ÅäºÏ¿ª·¢²¢ÉÌÒµ»¯ÏÂÒ»´ú³¤Ð§Factor XI£¨FXI£©°ÐÏòС×ÌÈÅRNA£¨siRNA£©ÁÆ·¨SRSD107£¬ £¬£¬£¬£¬ÓÃÓÚÖÎÁÆÑªË¨¼°ÑªË¨Ë¨ÈûÐÔ¼²²¡¡£¡£¡£¡£¡£¡£

¿Æ¼¼Ò©ÑÐ

1. ¿ËÈÕ£¬ £¬£¬£¬£¬À´×ÔÃÀ¹ú˹̹¸£´óѧµÄMaximilian DiehnÍŶÓÔÚNatureÔÚÏß½ÒÏþÌâΪAn ultrasensitive method for detection of cell-free RNAµÄÎÄÕ£¬ £¬£¬£¬£¬¿ª·¢ÁËÒ»ÖÖרÃÅÕë¶ÔcfRNAÆÊÎöµÄÓÅ»¯µÄ¼ì²âÒªÁ졪¡ªRARE-seq£¨Ëæ»úÒýÎïºÍÇ׺Ͳ¶»ñcfRNAƬ¶Ï¾ÙÐи»¼¯ÆÊÎöµÄ²âÐòÒªÁ죩£¬ £¬£¬£¬£¬Æä¿ÉÒÔÔÚ¼á³ÖÖ×Áö³õʼ°©Ö¢¼ì²âµÄ¸ß¶ÈÌØÒìÐÔµÄͬʱ£¬ £¬£¬£¬£¬Ìá¸ß¶ÔctRNAµÄ¼ì²â¼«ÏÞ£¬ £¬£¬£¬£¬²¢Ì½Ë÷ÁËRARE-seqÔÚ¶àÖÖÁÙ´²Ó¦ÓÃÖеÄDZÔÚÓÃ;£¬ £¬£¬£¬£¬°üÀ¨ÎÞ´´ctRNA»ùÒò·ÖÐÍ¡¢ÖÎÁÆÄÍÒ©ÐÔ¼à²â¡¢TOOÆÊÎöÒÔ¼°·Ç¶ñÐÔ¼²²¡µÄ·Ö×Ó±íÕ÷¡£¡£¡£¡£¡£¡£

[1]Nesselbush, M.C., Luca, B.A., Jeon, YJ. et al. An ultrasensitive method for detection of cell-free RNA. Nature 641, 759¨C768 (2025). https://doi.org/10.1038/s41586-025-08834-1

Ïà¹ØÐÂÎÅ
·ÂÖÆÒ©·ÂµÃÌ«ÏñÒ²ÊÇ´í£º°¢Ë¹Àû¿µPKÈðµÏ
2016-09-09
°¢Ë¹Àû¿µÑз¢ºÍÉú²úµÄÄÍÐÅ£¬ £¬£¬£¬£¬Ò»¾­ÊÇÖÆÒ©Òµ×îΪ´«ÆæµÄÖØ°õÕ¨µ¯£¬ £¬£¬£¬£¬¸ÃÒ©¿ÉÓÃÓÚÖÎÁÆÎ¸×ÆÈÈ¡¢Î¸Ê³¹Ü·µÁ÷²¡¡¢Î¸À£ÑñºÍʳµÀË𻵣¬ £¬£¬£¬£¬¿ÉÔ¤·ÀÒòֹʹҩÒý·¢µÄθ²¡¡£¡£¡£¡£¡£¡£
°¢Ë¹Àû¿µÃÆÉù·¢´ó²Æ»ñµÃFDAµÚ7ÕÅÓÅÏÈÉóÆÀȯ
2015-09-14
9ÔÂ2ÈÕ£¬ £¬£¬£¬£¬FDAÅú×¼ÁËÊ׸öÖÎÁÆÒÅ´«ÐÔÈéÇåËáÄòÖ¢µÄÒ©ÎïXuriden£¨ÄòÜÕÈýÒÒËáõ¥£©£¬ £¬£¬£¬£¬ÕâÊÇÒ»ÖÖÓÐÊýµÄ´úл¼²²¡£¬ £¬£¬£¬£¬È«Çò±¨µÀ²¡Àý½ö20Àý×óÓÒ¡£¡£¡£¡£¡£¡£
FDAÅú×¼°¢Ë¹Àû¿µÒ×ÈðɳÖÎÁÆÍíÆÚEGFRÍ»±äÑôÐԷΰ©
2015-07-15
°¢Ë¹Àû¿µ£¨AstraZeneca£©Ö×Áöѧ¹ÜÏßÔÚî¿Ïµ·½ÃæÊÕ»ñϲѶ£¬ £¬£¬£¬£¬FDA¿ËÈÕÅú×¼°ÐÏòÖÎÁÆÒ©ÎïÒ×Èðɳ£¨Iressa£¬ £¬£¬£¬£¬Í¨ÓÃÃû£ºgefitinib£¬ £¬£¬£¬£¬¼ª·ÇÌæÄᣩ×÷ΪһÖÖµ¥Ò©ÁÆ·¨£¬ £¬£¬£¬£¬ÓÃÓÚ¾­Ò»¿îFDAÅú×¼µÄÅãͬÕï¶ÏÊÔ¼ÁºÐ֤ʵΪ±íƤÉú³¤Òò×ÓÊÜÌ壨EGFR£©Í»±äÑôÐÔµÄ×ªÒÆÐÔ·ÇСϸ°û·Î°©£¨NSCLC£©»¼ÕßµÄÒ»ÏßÖÎÁÆ£¬ £¬£¬£¬£¬ÏêϸΪEGFR±£´æÍâÏÔ×Ó19ɾ³ýÍ»±ä»òÍâÏÔ×Ó21±£´æL858RÌæ»»Í»±ä¡£¡£¡£¡£¡£¡£
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿